Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 17/20 | 0.71 |
| ▸ | CA2 | P00918 | 17/20 | 0.71 |
| ▸ | MMP1 | P03956 | 1/20 | 0.62 |
| ▸ | MMP2 | P08253 | 1/20 | 0.62 |
| ▸ | MMP9 | P14780 | 1/20 | 0.62 |
| ▸ | MMP8 | P22894 | 1/20 | 0.62 |
| ▸ | MMP13 | P45452 | 1/20 | 0.62 |
| ▸ | F2 | P00734 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25737830 | 0.87 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL18426124 | 0.86 | CA1 (0.62) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL22909458 | 0.85 | CA1 (0.61) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL12386318 | 0.84 | CA1 (0.60) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL18535357 | 0.84 | CA1 (0.54) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL4175368 | 0.82 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL14189058 | 0.80 | CA1 (0.50) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL24842829 | 0.80 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL13462910 | 0.80 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL12129751 | 0.80 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1321996-B1 | Process of producing a polymer electrolyte membrane | SUMITOMO CHEMICAL CO (JP) | 2008-02-27 | — | — | EP | claimed |
| US-20240021874-A1 | Sulfonimide Salts for Battery Applications | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-01-18 | — | — | US | disclosed |
| US-20230217677-A1 | Organic Electronic Device Comprising a Substrate, an Anode Layer, a Cathode Layer, at Least One First Emission Layer, and a Hole Injection Layer That Comprises a Metal Complex | NOVALED GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-20230126203-A1 | An Organic Electronic Device Comprising an Anode Layer, a Cathode Layer, at Least One Emission Layer (EML) and at Least One Hole Injection Layer (HIL) | NOVALED GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230131369-A1 | An Organic Electronic Device Comprising a Hole Injection Layer That Comprises a Hole Transport Compound | NOVALED GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| US-11594696-B2 | Organic electronic component and method for producing an organic electronic component | PICTIVA DISPLAYS INTERNATIONAL LIMITED | 2023-02-28 | — | — | US | disclosed |
| US-20230056322-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-20210091412-A1 | SULFONIMIDE SALTS FOR BATTERY APPLICATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-03-25 | — | — | US | disclosed |
| US-10892520-B2 | Sulfonimide salts for battery applications | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-01-12 | — | — | US | disclosed |
| US-20200343468-A1 | ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT | DOLYA HOLDCO 5 LIMITED (IE) | 2020-10-29 | — | — | US | disclosed |
| US-20100047661-A1 | POLYMER LAMINATE MEMBRANE, THE METHOD FOR PRODUCING THE MEMBRANE AND THE USE OF THE MEMBRANE | SUMITOMO CHEMICAL COMPANY, LIMITED | 2010-02-25 | — | — | US | disclosed |
| US-7638220-B2 | Polymeric laminates, processes for producing the same, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7629106-B2 | Resist composition and patterning process using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-7618683-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2009-11-17 | — | — | US | disclosed |
| US-7618683-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2009-11-17 | — | — | US | disclosed |
| US-7303852-B2 | Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-12-04 | — | — | US | disclosed |
| US-7303852-B2 | Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-12-04 | — | — | US | disclosed |
| US-20070160815-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
| US-20070160815-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
| US-20070111140-A1 | Resist composition and patterning process using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230056322-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP1B1, CYP1A1 | CA1 1881/4885CA2 3827/4885MMP1 3607/4885 |
| US-10892520-B2 | Sulfonimide salts for battery applications | TST, EWSR1, SCLY | CA1 526/4885CA2 516/4885MMP1 2211/4885 |
| US-20210091412-A1 | SULFONIMIDE SALTS FOR BATTERY APPLICATIONS | TST, EWSR1, SCLY | CA1 526/4885CA2 516/4885MMP1 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.